Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 225

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 225
---
22, 2024, the Company issued 50,000 shares of Common Stock to a vendor in considerations for the services provided
by the vendor to the Company.

On
November 18, 2024, the Company issued 25,000 shares of Common Stock to a vendor in considerations for the services provided
by the vendor to the Company.

During
the year ended December 31, 2024, the Company issued 16,667 shares of Common Stock to a vendor in considerations for
the services provided by the vendor to the Company, with such shares granted on October 22, 2024.

Committed
Equity Financing

On
July 26, 2024, the Company entered into a Common Stock Purchase Agreement, dated as of July 26, 2024 (the “CEF Purchase
Agreement”), with Tikkun Capital LLC (“Tikkun”), providing for a committed equity financing facility, pursuant
to which, upon the terms and subject to the satisfaction of the conditions contained in the CEF Purchase Agreement, Tikkun has
committed to purchase, at the Company’s direction in its sole discretion, up to an aggregate of $30,000,000 (the “Total
Commitment”) of the shares of Common Stock (the “Purchase Shares”), subject to certain limitations set forth
in the CEF Purchase Agreement, from time to time during the term of the CEF Purchase Agreement. Concurrently with the execution
of the CEF Purchase Agreement, the Company and Tikkun also entered into a Registration Rights Agreement, dated as of July 26,
2024, pursuant to which the Company agreed to file with the SEC one or more registration statements, to register under the Securities
Act, the offer and resale by Tikkun of all of the Purchase Shares that may be issued and sold by the Company to Tikkun from time
to time under the CEF Purchase Agreement.

    F-21 

Stock
Repurchase Plan

On August 5, 2024, the Board authorized a stock repurchase plan (the “Repurchase Plan”) pursuant
to which up to $250,000 of the Company’s Common Stock may be repurchased prior to December 31, 2024, unless completed
sooner or otherwise extended. During the year ended December 31, 2024, the Company repurchased 86,196 shares of Common
Stock for $75,000. The 86,186 shares of